Submission Details
| 510(k) Number | K220254 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2022 |
| Decision Date | November 30, 2022 |
| Days to Decision | 303 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K220254 is an FDA 510(k) clearance for the Neuron-Spectrum-AM with Neuron-Spectrum.NET Software, a Non-normalizing Quantitative Electroencephalograph Software (Class II — Special Controls, product code OLT), submitted by Neurosoft , Ltd. (Ivanovo, RU). The FDA issued a Cleared decision on November 30, 2022, 303 days after receiving the submission on January 31, 2022. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K220254 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2022 |
| Decision Date | November 30, 2022 |
| Days to Decision | 303 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OLT — Non-normalizing Quantitative Electroencephalograph Software |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User. |